Annual CFO:
-$205.79M+$295.21M(+58.92%)Summary
- As of today, SRPT annual cash from operations is -$205.79 million, with the most recent change of +$295.21 million (+58.92%) on December 31, 2024.
- During the last 3 years, SRPT annual cash from operations has risen by +$237.38 million (+53.56%).
- SRPT annual cash from operations is now -291.49% below its all-time high of $107.47 million, reached on December 31, 2020.
Performance
SRPT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$27.37M-$288.71M(-110.47%)Summary
- As of today, SRPT quarterly cash from operations is -$27.37 million, with the most recent change of -$288.71 million (-110.47%) on September 30, 2025.
- Over the past year, SRPT quarterly cash from operations has increased by +$43.33 million (+61.28%).
- SRPT quarterly cash from operations is now -104.36% below its all-time high of $627.79 million, reached on March 31, 2020.
Performance
SRPT Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$257.43M+$43.33M(+14.41%)Summary
- As of today, SRPT TTM cash from operations is -$257.43 million, with the most recent change of +$43.33 million (+14.41%) on September 30, 2025.
- Over the past year, SRPT TTM cash from operations has increased by +$95.06 million (+26.97%).
- SRPT TTM cash from operations is now -182.19% below its all-time high of $313.22 million, reached on March 31, 2020.
Performance
SRPT TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SRPT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +58.9% | +61.3% | +27.0% |
| 3Y3 Years | +53.6% | +57.9% | +1.9% |
| 5Y5 Years | +54.9% | +88.5% | -326.1% |
SRPT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +58.9% | -110.5% | +95.3% | -25.1% | +53.0% |
| 5Y | 5-Year | -291.5% | +58.9% | -110.5% | +95.3% | -326.1% | +63.3% |
| All-Time | All-Time | -291.5% | +58.9% | -104.4% | +95.3% | -182.2% | +63.3% |
SRPT Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$27.37M(-110.5%) | -$257.43M(+14.4%) |
| Jun 2025 | - | $261.34M(+144.8%) | -$300.75M(+45.0%) |
| Mar 2025 | - | -$583.44M(-733.9%) | -$547.15M(-165.9%) |
| Dec 2024 | -$205.79M(+58.9%) | $92.05M(+230.2%) | -$205.79M(+41.6%) |
| Sep 2024 | - | -$70.70M(-573.2%) | -$352.49M(+11.1%) |
| Jun 2024 | - | $14.94M(+106.2%) | -$396.50M(+25.7%) |
| Mar 2024 | - | -$242.08M(-342.9%) | -$533.67M(-6.5%) |
| Dec 2023 | -$500.99M(-54.0%) | -$54.66M(+52.4%) | -$500.99M(+7.0%) |
| Sep 2023 | - | -$114.71M(+6.2%) | -$538.73M(-10.2%) |
| Jun 2023 | - | -$122.23M(+41.6%) | -$488.99M(-12.8%) |
| Mar 2023 | - | -$209.40M(-126.6%) | -$433.57M(-33.3%) |
| Dec 2022 | -$325.35M(+26.6%) | -$92.39M(-42.2%) | -$325.35M(-24.0%) |
| Sep 2022 | - | -$64.96M(+2.8%) | -$262.28M(+18.5%) |
| Jun 2022 | - | -$66.81M(+34.0%) | -$321.64M(+11.6%) |
| Mar 2022 | - | -$101.17M(-245.0%) | -$363.98M(+17.9%) |
| Dec 2021 | -$443.17M(-512.4%) | -$29.33M(+76.4%) | -$443.17M(+24.7%) |
| Sep 2021 | - | -$124.33M(-13.9%) | -$588.38M(+16.2%) |
| Jun 2021 | - | -$109.15M(+39.5%) | -$702.24M(-0.2%) |
| Mar 2021 | - | -$180.37M(-3.3%) | -$700.70M(-752.0%) |
| Dec 2020 | $107.47M(+123.5%) | -$174.53M(+26.7%) | $107.47M(-5.6%) |
| Sep 2020 | - | -$238.19M(-121.4%) | $113.87M(-60.0%) |
| Jun 2020 | - | -$107.60M(-117.1%) | $284.62M(-9.1%) |
| Mar 2020 | - | $627.79M(+473.4%) | $313.22M(+168.0%) |
| Dec 2019 | -$456.46M(-17.4%) | -$168.13M(-149.3%) | -$460.80M(-11.0%) |
| Sep 2019 | - | -$67.43M(+14.6%) | -$415.09M(+10.0%) |
| Jun 2019 | - | -$79.00M(+46.0%) | -$460.98M(+7.7%) |
| Mar 2019 | - | -$146.23M(-19.5%) | -$499.23M(-28.4%) |
| Dec 2018 | -$388.66M(-67.5%) | -$122.42M(-8.0%) | -$388.66M(-30.7%) |
| Sep 2018 | - | -$113.32M(+3.4%) | -$297.30M(-22.9%) |
| Jun 2018 | - | -$117.25M(-228.7%) | -$241.88M(-15.3%) |
| Mar 2018 | - | -$35.67M(-14.8%) | -$209.78M(+9.6%) |
| Dec 2017 | -$232.00M(+5.6%) | -$31.06M(+46.4%) | -$232.00M(+17.8%) |
| Sep 2017 | - | -$57.90M(+32.0%) | -$282.17M(+1.0%) |
| Jun 2017 | - | -$85.15M(-47.1%) | -$284.88M(-17.2%) |
| Mar 2017 | - | -$57.89M(+28.7%) | -$243.02M(+1.1%) |
| Dec 2016 | -$245.82M(-64.5%) | -$81.23M(-34.0%) | -$245.82M(-25.5%) |
| Sep 2016 | - | -$60.62M(-40.0%) | -$195.86M(-7.9%) |
| Jun 2016 | - | -$43.28M(+28.7%) | -$181.56M(-8.8%) |
| Mar 2016 | - | -$60.69M(-94.1%) | -$166.81M(-11.6%) |
| Dec 2015 | -$149.47M(-16.3%) | -$31.27M(+32.5%) | -$149.47M(-4.1%) |
| Sep 2015 | - | -$46.31M(-62.3%) | -$143.64M(-8.3%) |
| Jun 2015 | - | -$28.53M(+34.2%) | -$132.65M(+7.6%) |
| Mar 2015 | - | -$43.35M(-70.3%) | -$143.62M(-11.7%) |
| Dec 2014 | -$128.54M(-98.7%) | -$25.45M(+27.9%) | -$128.54M(-6.3%) |
| Sep 2014 | - | -$35.32M(+10.6%) | -$120.91M(-14.6%) |
| Jun 2014 | - | -$39.50M(-39.8%) | -$105.47M(-35.3%) |
| Mar 2014 | - | -$28.27M(-58.6%) | -$77.97M(-20.5%) |
| Dec 2013 | -$64.69M(-117.9%) | -$17.82M(+10.3%) | -$64.69M(-19.7%) |
| Sep 2013 | - | -$19.88M(-65.6%) | -$54.03M(-28.8%) |
| Jun 2013 | - | -$12.00M(+19.9%) | -$41.96M(-17.7%) |
| Mar 2013 | - | -$14.99M(-109.5%) | -$35.64M(-20.0%) |
| Dec 2012 | -$29.69M(-25.4%) | -$7.16M(+8.3%) | -$29.69M(-5.4%) |
| Sep 2012 | - | -$7.80M(-37.4%) | -$28.18M(-1.0%) |
| Jun 2012 | - | -$5.68M(+37.2%) | -$27.90M(-23.1%) |
| Mar 2012 | - | -$9.05M(-60.2%) | -$22.66M(+4.3%) |
| Dec 2011 | -$23.68M | -$5.65M(+24.9%) | -$23.68M(-18.9%) |
| Sep 2011 | - | -$7.52M(-1602.0%) | -$19.92M(-31.3%) |
| Jun 2011 | - | -$442.00K(+95.6%) | -$15.17M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$10.07M(-433.2%) | -$18.96M(-24.7%) |
| Dec 2010 | -$15.21M(-72.8%) | -$1.89M(+31.9%) | -$15.21M(-5.8%) |
| Sep 2010 | - | -$2.77M(+34.5%) | -$14.38M(-7.8%) |
| Jun 2010 | - | -$4.24M(+32.9%) | -$13.34M(+1.1%) |
| Mar 2010 | - | -$6.31M(-497.2%) | -$13.50M(-53.4%) |
| Dec 2009 | -$8.80M(+28.7%) | -$1.06M(+39.2%) | -$8.80M(+13.9%) |
| Sep 2009 | - | -$1.74M(+60.4%) | -$10.22M(+19.6%) |
| Jun 2009 | - | -$4.39M(-171.8%) | -$12.71M(-33.4%) |
| Mar 2009 | - | -$1.61M(+34.7%) | -$9.53M(+22.8%) |
| Dec 2008 | -$12.34M(+50.0%) | -$2.47M(+41.5%) | -$12.34M(+28.2%) |
| Sep 2008 | - | -$4.23M(-249.1%) | -$17.19M(+2.2%) |
| Jun 2008 | - | -$1.21M(+72.6%) | -$17.58M(+25.5%) |
| Mar 2008 | - | -$4.43M(+39.6%) | -$23.61M(+4.3%) |
| Dec 2007 | -$24.68M(-19.7%) | -$7.33M(-58.6%) | -$24.68M(-9.7%) |
| Sep 2007 | - | -$4.62M(+36.2%) | -$22.49M(+4.1%) |
| Jun 2007 | - | -$7.24M(-31.7%) | -$23.45M(-12.6%) |
| Mar 2007 | - | -$5.49M(-6.8%) | -$20.82M(-1.0%) |
| Dec 2006 | -$20.61M(-40.5%) | -$5.15M(+7.6%) | -$20.61M(-1.9%) |
| Sep 2006 | - | -$5.57M(-20.9%) | -$20.24M(-30.6%) |
| Jun 2006 | - | -$4.61M(+12.8%) | -$15.50M(+0.5%) |
| Mar 2006 | - | -$5.29M(-10.9%) | -$15.58M(-6.2%) |
| Dec 2005 | -$14.67M(+38.3%) | -$4.77M(-475.4%) | -$14.67M(-10.0%) |
| Sep 2005 | - | -$828.90K(+82.3%) | -$13.33M(+26.5%) |
| Jun 2005 | - | -$4.69M(-7.1%) | -$18.15M(+11.2%) |
| Mar 2005 | - | -$4.38M(-27.6%) | -$20.43M(+14.1%) |
| Dec 2004 | -$23.78M(-36.0%) | -$3.43M(+39.2%) | -$23.78M(+4.8%) |
| Sep 2004 | - | -$5.65M(+19.0%) | -$24.98M(-9.6%) |
| Jun 2004 | - | -$6.97M(+9.8%) | -$22.79M(-20.8%) |
| Mar 2004 | - | -$7.73M(-67.0%) | -$18.86M(-7.9%) |
| Dec 2003 | -$17.48M(+13.7%) | -$4.63M(-33.8%) | -$17.48M(-6.1%) |
| Sep 2003 | - | -$3.46M(-13.6%) | -$16.47M(+2.8%) |
| Jun 2003 | - | -$3.04M(+52.0%) | -$16.94M(+23.5%) |
| Mar 2003 | - | -$6.35M(-75.4%) | -$22.14M(-9.3%) |
| Dec 2002 | -$20.26M(-58.0%) | -$3.62M(+7.8%) | -$20.26M(+0.2%) |
| Sep 2002 | - | -$3.93M(+52.3%) | -$20.31M(-5.3%) |
| Jun 2002 | - | -$8.24M(-84.2%) | -$19.28M(-32.9%) |
| Mar 2002 | - | -$4.47M(-22.1%) | -$14.51M(-13.1%) |
| Dec 2001 | -$12.82M(-40.5%) | -$3.66M(-26.0%) | -$12.82M(-2.8%) |
| Sep 2001 | - | -$2.91M(+16.1%) | -$12.48M(-10.7%) |
| Jun 2001 | - | -$3.46M(-24.1%) | -$11.27M(-7.3%) |
| Mar 2001 | - | -$2.79M(+15.9%) | -$10.50M(-15.0%) |
| Dec 2000 | -$9.13M(-20.1%) | -$3.32M(-95.2%) | -$9.13M(-18.8%) |
| Sep 2000 | - | -$1.70M(+36.9%) | -$7.68M(+2.0%) |
| Jun 2000 | - | -$2.69M(-90.1%) | -$7.84M(-6.6%) |
| Mar 2000 | - | -$1.42M(+24.3%) | -$7.36M(+2.7%) |
| Dec 1999 | -$7.60M(-13.4%) | -$1.87M(-1.0%) | -$7.56M(+4.5%) |
| Sep 1999 | - | -$1.86M(+16.1%) | -$7.91M(-25.1%) |
| Jun 1999 | - | -$2.21M(-36.3%) | -$6.32M(+2.4%) |
| Mar 1999 | - | -$1.62M(+27.1%) | -$6.48M(+3.9%) |
| Dec 1998 | -$6.70M(-123.3%) | -$2.23M(-738.3%) | -$6.74M(-20.1%) |
| Sep 1998 | - | -$265.50K(+88.8%) | -$5.61M(+11.6%) |
| Jun 1998 | - | -$2.36M(-25.6%) | -$6.35M(-41.6%) |
| Mar 1998 | - | -$1.88M(-71.0%) | -$4.48M(-49.4%) |
| Dec 1997 | -$3.00M(-87.5%) | -$1.10M(-10.0%) | -$3.00M(-57.9%) |
| Sep 1997 | - | -$1.00M(-100.0%) | -$1.90M(-111.1%) |
| Jun 1997 | - | -$500.00K(-25.0%) | -$900.00K(-125.0%) |
| Mar 1997 | - | -$400.00K | -$400.00K |
| Dec 1996 | -$1.60M | - | - |
FAQ
- What is Sarepta Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Sarepta Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Sarepta Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Sarepta Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of SRPT is -$205.79M
What is the all-time high annual cash from operations for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high annual cash from operations is $107.47M
What is Sarepta Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, SRPT annual cash from operations has changed by +$295.21M (+58.92%)
What is Sarepta Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of SRPT is -$27.37M
What is the all-time high quarterly cash from operations for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high quarterly cash from operations is $627.79M
What is Sarepta Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, SRPT quarterly cash from operations has changed by +$43.33M (+61.28%)
What is Sarepta Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of SRPT is -$257.43M
What is the all-time high TTM cash from operations for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high TTM cash from operations is $313.22M
What is Sarepta Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, SRPT TTM cash from operations has changed by +$95.06M (+26.97%)